NIH-funded research NIH-funded research

Understanding how staphylococcal proteins help bacteria form protective communities

Official title: Structure and function of staphylococcal surface proteins involved in biofilm growth and virulence

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11159465 · Data updated 2026-11-12

This study is looking at how certain proteins help bacteria stick together and form tough clusters called biofilms, which can make infections harder to treat, and it aims to find new ways to break up these biofilms to help people recover better from infections caused by these bacteria.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startAugust 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$401,250
NIH project number5R35GM151986-02
Project IDNIH-11159465 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections related to Staphylococcus species, particularly those with antibiotic-resistant strains.

Less likely to help

Patients with infections caused by non-staphylococcal bacteria or those who do not have antibiotic-resistant infections may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms by which certain proteins on the surface of Staphylococcus epidermidis and S. aureus contribute to the formation of biofilms, which are clusters of bacteria that adhere to surfaces and are resistant to antibiotics. The study will focus on specific proteins that promote bacterial adhesion and the formation of these biofilm communities. By examining how these proteins interact and contribute to biofilm stability, the research aims to identify potential therapeutic targets to disrupt biofilm formation and improve treatment outcomes for infections caused by these bacteria.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing and treating persistent infections caused by antibiotic-resistant bacteria.

How similar studies have gone: Previous research has shown success in targeting biofilm formation in other bacterial species, suggesting that similar approaches may be effective for staphylococcal infections.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Herr, Andrew B — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Herr, Andrew B

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.